Free Trial

Bridgefront Capital LLC Purchases New Position in Enovix Co. (NASDAQ:ENVX)

Enovix logo with Energy background

Bridgefront Capital LLC acquired a new position in shares of Enovix Co. (NASDAQ:ENVX - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 46,608 shares of the company's stock, valued at approximately $507,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ENVX. Fifth Third Bancorp grew its stake in shares of Enovix by 66.7% in the 4th quarter. Fifth Third Bancorp now owns 2,500 shares of the company's stock worth $27,000 after buying an additional 1,000 shares in the last quarter. Coppell Advisory Solutions LLC bought a new stake in Enovix during the fourth quarter worth approximately $27,000. Sava Infond d.o.o. purchased a new stake in Enovix during the fourth quarter valued at approximately $43,000. Hollencrest Capital Management boosted its holdings in shares of Enovix by 61.4% in the 4th quarter. Hollencrest Capital Management now owns 5,256 shares of the company's stock worth $57,000 after purchasing an additional 2,000 shares during the period. Finally, R Squared Ltd bought a new position in shares of Enovix during the 4th quarter valued at approximately $64,000. 50.92% of the stock is currently owned by institutional investors.

Enovix Stock Up 1.7 %

ENVX stock traded up $0.11 during trading on Friday, reaching $6.59. 4,075,403 shares of the company traded hands, compared to its average volume of 6,074,323. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of -4.54 and a beta of 1.99. The company has a debt-to-equity ratio of 0.99, a quick ratio of 3.61 and a current ratio of 3.77. The business has a 50 day simple moving average of $6.98 and a 200 day simple moving average of $9.16. Enovix Co. has a 12 month low of $5.27 and a 12 month high of $18.68.

Enovix (NASDAQ:ENVX - Get Free Report) last posted its earnings results on Wednesday, February 19th. The company reported ($0.17) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $0.01. The company had revenue of $9.72 million during the quarter, compared to analysts' expectations of $8.77 million. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. On average, equities research analysts anticipate that Enovix Co. will post -1.01 earnings per share for the current fiscal year.

Insider Buying and Selling at Enovix

In other news, CEO Rajendra K. Talluri sold 300,000 shares of the firm's stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $9.35, for a total value of $2,805,000.00. Following the completion of the transaction, the chief executive officer now directly owns 2,045,301 shares in the company, valued at $19,123,564.35. This trade represents a 12.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 15.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms recently commented on ENVX. TD Securities dropped their price target on shares of Enovix from $10.00 to $7.00 and set a "hold" rating for the company in a research note on Thursday, May 1st. Craig Hallum decreased their price target on Enovix from $20.00 to $18.00 and set a "buy" rating for the company in a research note on Thursday, February 20th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $30.00 price objective on shares of Enovix in a research report on Thursday, February 20th. Benchmark reduced their price target on shares of Enovix from $25.00 to $15.00 and set a "buy" rating on the stock in a research note on Tuesday, April 15th. Finally, B. Riley reduced their target price on shares of Enovix from $17.00 to $12.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $17.27.

View Our Latest Stock Report on Enovix

Enovix Company Profile

(Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Read More

Institutional Ownership by Quarter for Enovix (NASDAQ:ENVX)

Should You Invest $1,000 in Enovix Right Now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines